IDEAYA Biosciences (IDYA) Operating Income Growth (5y) (2023 - 2026)
IDEAYA Biosciences (IDYA) Operating Income Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.05% |
| Dec 31, 2025 | -78.08% |
| Sep 30, 2025 | 88.36% |
| Jun 30, 2025 | -47.80% |
| Mar 31, 2025 | -46.56% |
| Dec 31, 2024 | -66.34% |
| Sep 30, 2024 | -41.91% |
| Jun 30, 2024 | -42.03% |
| Mar 31, 2024 | -38.27% |
| Dec 31, 2023 | -35.63% |
| Sep 30, 2023 | -19.73% |
| Jun 30, 2023 | -34.00% |